Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

Clinical trial NCT04096690 · UNKNOWN

Trial details

NCT number: NCT04096690
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasal Type Extranodal NK/T-Cell Lymphoma

Start date: 2019-09-10
Primary completion: 2021-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.